|
NaprosynDrug - Naprosyn The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Naproxen
Strength -
250MG
Applicant -
ROCHE PALO
New Drug Application (NDA) Number -
017581
Product Number -
002
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Roche Palo Alto Llc
Naprosyn
Naproxen 500mg Tablet, Delayed Release; Oral
Naprosyn 250mg Tablet; Oral Naproxen 500mg Tablet, Delayed Release; Oral Naproxen 375mg Tablet, Delayed Release; Oral Naproxen 500mg Tablet, Delayed Release; Oral Naproxen 375mg Tablet, Delayed Release; Oral Naproxen 500mg Tablet, Delayed Release; Oral Naproxen 375mg Tablet, Delayed Release; Oral Naproxen 500mg Tablet, Delayed Release; Oral Naproxen 375mg Tablet, Delayed Release; Oral NewDrugInformation |